| abstract |
Formula I, in free or salt form [Chemical 1] [Wherein R 1 , R 2 and R 3 have the meanings described in the specification. ] These compounds are useful for the treatment of conditions mediated by activation of the adenosine A 2A receptor, particularly inflammatory or obstructive airway diseases. Also described are pharmaceutical compositions containing the compounds and methods of making the compounds. |